G04.81
Other encephalitis and encephalomyelitis
Clinical Classification Guidelines
Inclusion Terms
- Noninfectious acute disseminated encephalomyelitis (noninfectious ADEM)
Medical Intelligence & Overview
Noninfectious acute disseminated encephalomyelitis (ADEM) is a rare neurological condition characterized by inflammation of the brain and spinal cord. It falls under the category of encephalitis and encephalomyelitis, specifically marked by its noninfectious nature. Unlike infections that cause similar symptoms, noninfectious ADEM involves an autoimmune response, where the body's immune system mistakenly targets its own nervous tissue. This condition can develop rapidly, leading to various neurological symptoms, and often requires prompt recognition and management to prevent long-term complications.
Causes & Symptoms
Clinical Causes: Autoimmune reactions sometimes triggered by recent infections such as measles, mumps, or chickenpox Recent vaccinations, which can stimulate the immune system abnormally in rare cases Unknown factors, where no clear cause can be identified Genetic predispositions that may increase susceptibility Other immune-mediated conditions that cause the immune system to attack the nervous tissue
Key Symptoms: Sudden onset of neurological deficits Headache and flu-like symptoms often precede neurological signs Weakness or paralysis in limbs Loss of sensation or numbness Difficulty with coordination and balance Altered mental state, including confusion or agitation Seizures in some cases Blurred vision or other visual disturbances Fever may be present but is typically low-grade
Diagnostic & Treatment
Diagnosis Path: Neurological examination to evaluate reflexes, motor skills, and coordination Magnetic Resonance Imaging (MRI) scans to identify areas of inflammation within the brain and spinal cord Lumbar puncture (spinal tap) to analyze cerebrospinal fluid for signs of inflammation Blood tests to rule out infections and other autoimmune conditions Electroencephalogram (EEG) if seizures are suspected
Treatment Protocols: High-dose corticosteroids, such as methylprednisolone, administered intravenously to decrease inflammation Plasmapheresis (plasma exchange) in severe cases to remove harmful antibodies from the blood Intravenous immunoglobulin (IVIG) therapy to modulate immune activity Supportive care including physical therapy, occupational therapy, and speech therapy to aid recovery Monitoring for potential relapses or long-term neurological issues
Clinical Advice & FAQs
Billing Guidance
Is G04.81 a billable ICD-10 code?
Yes, G04.81 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report G04.81?
Clinical documentation must specify the nature of Other encephalitis and encephalomyelitis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference